308 related articles for article (PubMed ID: 28068240)
1. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
[TBL] [Abstract][Full Text] [Related]
2. Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer.
Lee SF; Yip PL; Wong A; Ng F; Koh V; Wong LC; Luk H; Ng CK; Lee FAS; Mamon HJ
Clin Transl Radiat Oncol; 2022 Sep; 36():83-90. PubMed ID: 35909437
[TBL] [Abstract][Full Text] [Related]
3. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.
Wild AT; Herman JM; Dholakia AS; Moningi S; Lu Y; Rosati LM; Hacker-Prietz A; Assadi RK; Saeed AM; Pawlik TM; Jaffee EM; Laheru DA; Tran PT; Weiss MJ; Wolfgang CL; Ford E; Grossman SA; Ye X; Ellsworth SG
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):571-9. PubMed ID: 26867885
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
6. The relationship between splenic dose and radiation-induced lymphopenia.
Ma Y; Kong Y; Zhang S; Peng Y; Xu M; Zhang J; Xu H; Hong Z; Xing P; Qian J; Zhang L
J Radiat Res; 2024 May; 65(3):337-349. PubMed ID: 38718391
[TBL] [Abstract][Full Text] [Related]
7. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
8. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.
Liu J; Zhao Q; Deng W; Lu J; Xu X; Wang R; Li X; Yue J
Radiat Oncol; 2017 May; 12(1):90. PubMed ID: 28558844
[TBL] [Abstract][Full Text] [Related]
9. The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.
Wild AT; Ye X; Ellsworth SG; Smith JA; Narang AK; Garg T; Campian J; Laheru DA; Zheng L; Wolfgang CL; Tran PT; Grossman SA; Herman JM
Am J Clin Oncol; 2015 Jun; 38(3):259-65. PubMed ID: 23648440
[TBL] [Abstract][Full Text] [Related]
10. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
11. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy.
Ladbury CJ; Rusthoven CG; Camidge DR; Kavanagh BD; Nath SK
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):346-355. PubMed ID: 31175902
[TBL] [Abstract][Full Text] [Related]
12. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.
Krishnan S; Chadha AS; Suh Y; Chen HC; Rao A; Das P; Minsky BD; Mahmood U; Delclos ME; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):755-65. PubMed ID: 26972648
[TBL] [Abstract][Full Text] [Related]
13. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
[TBL] [Abstract][Full Text] [Related]
14. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
16. Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Okada M
Transl Cancer Res; 2021 Dec; 10(12):5076-5084. PubMed ID: 35116359
[TBL] [Abstract][Full Text] [Related]
17. Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes.
Wang X; Lu J; Teng F; Yu J
Ann Transl Med; 2019 Aug; 7(16):385. PubMed ID: 31555699
[TBL] [Abstract][Full Text] [Related]
18. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
